Metropolitan Life Insurance CO Ptc Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

55 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$24.15 - $31.95 $6,979 - $9,233	-289 Reduced 7.08%	3,793 $110,000
Q3 2023 Nov 14, 2023	BUY	$22.41 - $41.99 $5,176 - $9,699	231 Added 6.0%	4,082 $91,000
Q2 2023 Aug 10, 2023	BUY	$40.4 - $59.1 $3,312 - $4,846	82 Added 2.18%	3,851 $156,000
Q1 2023 May 15, 2023	SELL	$38.16 - $48.86 $21,827 - $27,947	-572 Reduced 13.18%	3,769 $182,000
Q4 2022 Jun 14, 2023	BUY	$33.53 - $54.79 $19,179 - $31,339	572 Added 15.18%	4,341 $166 Million
Q4 2022 Mar 30, 2023	BUY	$33.53 - $54.79 $3,386 - $5,533	101 Added 2.38%	4,341 $165,000
Q4 2022 Feb 15, 2023	BUY	$33.53 - $54.79 $3,386 - $5,533	101 Added 2.38%	4,341 $165,000
Q3 2022 Jun 14, 2023	BUY	$41.85 - $53.85 $19,711 - $25,363	471 Added 12.5%	4,240 $213 Million
Q2 2022 Jun 20, 2023	BUY	$25.6 - $45.23 $12,057 - $21,303	471 Added 12.5%	4,240 $169,000
Q2 2022 Mar 30, 2023	SELL	$25.6 - $45.23 $7,116 - $12,573	-278 Reduced 6.15%	4,240 $169,000
Q2 2022 Aug 11, 2022	SELL	$25.6 - $45.23 $7,116 - $12,573	-278 Reduced 6.15%	4,240 $170,000
Q1 2022 Jun 20, 2023	BUY	$33.33 - $44.6 $24,964 - $33,405	749 Added 19.87%	4,518 $168,000
Q1 2022 Mar 30, 2023	SELL	$33.33 - $44.6 $448,221 - $599,780	-13,448 Reduced 74.85%	4,518 $168,000
Q1 2022 May 12, 2022	SELL	$33.33 - $44.6 $448,221 - $599,780	-13,448 Reduced 74.85%	4,518 $169,000
Q4 2021 Jun 21, 2023	BUY	$35.36 - $41.86 $502,005 - $594,286	14,197 Added 376.68%	17,966 $715,000
Q4 2021 Mar 30, 2023	SELL	$35.36 - $41.86 $41,406 - $49,018	-1,171 Reduced 6.12%	17,966 $715,000
Q4 2021 Feb 15, 2022	SELL	$35.36 - $41.86 $41,406 - $49,018	-1,171 Reduced 6.12%	17,966 $716,000
Q3 2021 Jun 21, 2023	BUY	$37.01 - $44.74 $568,769 - $687,564	15,368 Added 407.75%	19,137 $712,000
Q3 2021 Mar 30, 2023	BUY	$37.01 - $44.74 $111 - $134	3 Added 0.02%	19,137 $712,000
Q3 2021 Nov 15, 2021	BUY	$37.01 - $44.74 $111 - $134	3 Added 0.02%	19,137 $712,000
Q2 2021 Jun 21, 2023	BUY	$37.95 - $49.37 $583,101 - $758,570	15,365 Added 407.67%	19,134 $808,000
Q2 2021 Mar 30, 2023	BUY	$37.95 - $49.37 $90,283 - $117,451	2,379 Added 14.2%	19,134 $808,000
Q2 2021 Aug 16, 2021	BUY	$37.95 - $49.37 $725,490 - $943,806	19,117 Added 112452.94%	19,134 $809,000
Q1 2021 Jun 26, 2023	BUY	$46.8 - $68.92 $607,744 - $894,995	12,986 Added 344.55%	16,755 $793 Million
Q1 2021 Mar 30, 2023	SELL	$46.8 - $68.92 $37,814 - $55,687	-808 Reduced 4.6%	16,755 $793,000
Q1 2021 May 14, 2021	SELL	$46.8 - $68.92 $821,152 - $1.21 Million	-17,546 Reduced 99.9%	17 $793,000
Q4 2020 Jun 22, 2023	BUY	$47.96 - $67.64 $661,560 - $933,026	13,794 Added 365.99%	17,563 $1.07 Million
Q4 2020 Mar 30, 2023	SELL	$47.96 - $67.64 $35,490 - $50,053	-740 Reduced 4.04%	17,563 $1.07 Million
Q4 2020 Feb 16, 2021	SELL	$47.96 - $67.64 $35,490 - $50,053	-740 Reduced 4.04%	17,563 $1.07 Million
Q3 2020 Jun 26, 2023	BUY	$45.41 - $57.07 $659,988 - $829,455	14,534 Added 385.62%	18,303 $855,000
Q3 2020 Mar 30, 2023	SELL	$45.41 - $57.07 $12,260 - $15,408	-270 Reduced 1.45%	18,303 $855,000
Q3 2020 Nov 13, 2020	SELL	$45.41 - $57.07 $12,260 - $15,408	-270 Reduced 1.45%	18,303 $856,000
Q2 2020 Jun 26, 2023	BUY	$42.56 - $54.98 $630,058 - $813,923	14,804 Added 392.78%	18,573 $942,000
Q1 2020 Jul 12, 2023	BUY	$32.37 - $59.36 $479,205 - $878,765	14,804 Added 392.78%	18,573 $828,000
Q1 2020 Mar 30, 2023	BUY	$32.37 - $59.36 $6,797 - $12,465	210 Added 1.14%	18,573 $828,000
Q1 2020 May 15, 2020	BUY	$32.37 - $59.36 $6,797 - $12,465	210 Added 1.14%	18,573 $829,000
Q4 2019 Jul 12, 2023	BUY	$32.22 - $50.07 $470,218 - $730,721	14,594 Added 387.21%	18,363 $881,000
Q4 2019 Mar 30, 2023	SELL	$32.22 - $50.07 $9,537 - $14,820	-296 Reduced 1.59%	18,363 $881,000
Q4 2019 Feb 14, 2020	SELL	$32.22 - $50.07 $9,537 - $14,820	-296 Reduced 1.59%	18,363 $882,000
Q3 2019 Jul 12, 2023	BUY	$33.82 - $48.17 $503,579 - $717,251	14,890 Added 395.07%	18,659 $631,000
Q3 2019 Mar 30, 2023	BUY	$33.82 - $48.17 $72,679 - $103,517	2,149 Added 13.02%	18,659 $631,000
Q3 2019 Nov 14, 2019	BUY	$33.82 - $48.17 $72,679 - $103,517	2,149 Added 13.02%	18,659 $631,000
Q2 2019 Jul 12, 2023	BUY	$35.42 - $45.0 $468,854 - $595,665	13,237 Added 351.21%	17,006 $765,000
Q1 2019 Jul 13, 2023	BUY	$28.09 - $39.49 $357,894 - $503,142	12,741 Added 338.05%	16,510 $621,000
Q1 2019 Mar 30, 2023	BUY	$28.09 - $39.49 $341,827 - $480,553	12,169 Added 280.33%	16,510 $621,000
Q1 2019 May 16, 2019	SELL	$28.09 - $39.49 $421,687 - $592,823	-15,012 Reduced 47.62%	16,510 $621,000
Q1 2019 May 15, 2019	BUY	$28.09 - $39.49 $458,962 - $645,227	16,339 Added 107.61%	31,522 $1.38 Million
Q4 2018 Jul 13, 2023	BUY	$29.83 - $46.51 $340,479 - $530,865	11,414 Added 302.84%	15,183 $521,000
Q4 2018 Feb 14, 2019	BUY	$29.83 - $46.51 $358,675 - $559,236	12,024 Added 380.63%	15,183 $521,000
Q3 2018 Jul 13, 2023	BUY	$33.9 - $47.77 $372,900 - $525,470	11,000 Added 291.85%	14,769 $694 Million
Q3 2018 Nov 14, 2018	SELL	$33.9 - $47.77 $393,579 - $554,609	-11,610 Reduced 78.61%	3,159 $148,000
Q2 2018 Aug 15, 2018	BUY	$25.7 - $47.88 $45,052 - $83,933	1,753 Added 13.47%	14,769 $0
Q4 2017 Feb 15, 2018	SELL	$15.14 - $20.89 $217,667 - $300,335	-14,377 Reduced 52.48%	13,016 $217,000
Q3 2017 Nov 14, 2017	BUY	$16.81 - $21.61 $64,937 - $83,479	3,863 Added 16.42%	27,393 $548,000
Q2 2017 Aug 14, 2017	BUY	N/A	23,530	23,530 $431,000

Others Institutions Holding PTCT

# of Institutions

219

Shares Held

78.2M

Call Options Held

111K

Put Options Held

30.6K

Vanguard Group Inc Valley Forge, PA

9.13M
Shares

$387 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

7.89M
Shares

$334 Million
0.05% of portfolio
Black Rock Inc. New York, NY

7.77M
Shares

$329 Million
0.01% of portfolio
Rtw Investments, LP New York, NY

7.39M
Shares

$313 Million
4.37% of portfolio
Armistice Capital, LLC New York, NY

7.23M
Shares

$307 Million
4.46% of portfolio

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.03B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account